Early October 2021 LabCoP Extended ECHO Session: Screening for LTBI in Resource-Limited Settings and Solutions to Meet EndTB Goals
On 14 October 2021 this Extended ECHO session was convened to discuss the basics of latent tuberculosis infection (LTBI), the critical importance of screening for LTBI in addition
COVID-19 ECHO Session #49: Manufacturers of COVID-19 Diagnostics: Siemens & Thermo Fisher
On 16 September 2021, ASLM’s LabCoP hosted another session in our series on manufacturers of COVID-19 diagnostics products. This session featured Siemens Healthineers and The
COVID-19 ECHO Session #48: The Evolving Role of Diagnostics in the COVID-19 Pandemic Response
On 9 September 2021, this COVID-19 ECHO session was convened to discuss the evolving role of diagnostics in the COVID-19 pandemic response. Testing, when used effectively, is one c
COVID-19 ECHO Session #47: SARS-CoV-2 Ag RDT e-Learning Course
On 7 September 2021, this COVID-19 ECHO session was convened by ASLM, in conjunction with Africa CDC, the Clinton Health Access Initiative, and Last Mile Health to provide an orien
August 2021 LabCoP ECHO Session: HIV VL Monitoring Among Patients on ART: Eight sub-Saharan African Countries, 2013–2018
LabCoP’s August 2021 ECHO session focused on sharing progress in HIV viral load (VL) monitoring among patients on antiretroviral therapy (ART) from eight sub-Saharan Africa count
July 2021 LabCoP ECHO Session: Unlocking the Potential of Tiered Laboratory Networks Through Laboratory Mapping
LabCoP’s July 2021 ECHO session focused on unlocking the potential of tiered laboratory networks through laboratory capacity mapping. Mapping the capacity of a national laborator
July 2021 LabCoP Extended ECHO Session: Innovating for Tuberculosis Diagnostics: MTB/XDR Assays and Considerations for Implementation
On 15 July 2021 this Extended ECHO session was convened to discuss the WHO`s End TB Strategy that requires universal drug susceptibility testing and treatment of all tuberculosis c
June 2021 LabCoP Extended Echo Session: Implementation of the Lateral-Flow Urine Lipoarbinomannan Assay
On 30 June 2021 this Extended ECHO session was convened to discuss the implementation of the Lateral-Flow Urine Lipoarabinomannan (LF-LAM) assay for the detection of active tubercu
June 2021 LabCoP ECHO Session: Generating Demand for HIV Viral Load Testing Through Targeted Communications Campaigns
LabCoP’s June 2021 ECHO session focussed on generating demand for HIV viral load (VL) testing through targeted communications campaigns. WHO recommends at least one annual VL tes
LabCoP M&E Sub-CoP ECHO Session June 2021
In June the ASLM LabCoP monitoring and evaluation (M&E) Sub-CoP held an ECHO session on viral load (VL) testing data quality assessment. The presentation provided an overview o